J&J and BHC Reach Deal On Body Powder Litigation

Introduction

In a U.S. Securities and Exchange Commission filing, Bausch Health Companies Inc. (BHC) struck a deal with Johnson & Johnson to cover the costs of litigation involved in personal injury and product liability lawsuits linked to Shower to Shower product that Bausch acquired in 2012.

The deal covers suits filed before March 2020. J&J will compensate Bausch for any regulatory actions related to the production, use or sale of the talcum powder up to September 2012. The lawsuits against Bausch included several filed into the multidistrict litigation involving J&J's talcum products in New Jersey federal court and state courts. Some of the cases claimed that Shower to Shower powder cause ovarian cancer to women who used them for personal hygiene purposes. The company stated in the annual report that it was actively defending itself in suits that have not been dismissed yet.

J&J faces more than 14,000 claims linked to asbestos exposure from its talc-based products causing ovarian cancer or mesothelioma.

Comments

NC to Get $150M to Boost Opioid Treatment, Recovery

Categories: Opioids

North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid…

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

J&J and BHC Reach Deal On Body Powder Litigation